Dupont Capital Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-1,293
| Closed | -$489K | – | 598 |
|
|
2015
Q2 | $489K | Sell |
1,293
-294
| -19% | -$111K | 0.01% | 521 |
|
|
2015
Q1 | $663K | Hold |
1,587
| – | – | 0.01% | 490 |
|
|
2014
Q4 | $434K | Sell |
1,587
-2,862
| -64% | -$783K | 0.01% | 556 |
|
|
2014
Q3 | $865K | Buy |
4,449
+353
| +9% | +$68.6K | 0.02% | 493 |
|
|
2014
Q2 | $1M | Buy |
4,096
+3,091
| +308% | +$757K | 0.02% | 498 |
|
|
2014
Q1 | $266K | Sell |
1,005
-696
| -41% | -$184K | ﹤0.01% | 607 |
|
|
2013
Q4 | $618K | Buy |
+1,701
| New | +$618K | 0.01% | 553 |
|